| NWHTX | VITAX | NWHTX / VITAX | |
| Total Expense Ratio | 0.68 | 0.09 | 756% |
| Annual Report Gross Expense Ratio | 0.73 | 0.09 | 811% |
| Fund Existence | 13 years | 22 years | - |
| Gain YTD | 23.632 | 31.841 | 74% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 100000 | 1,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 230M | 147B | 0% |
| Annual Yield % from dividends | 0.00 | 0.32 | - |
| Returns for 1 year | 27.17 | 62.42 | 44% |
| Returns for 3 years | 66.02 | 134.56 | 49% |
| Returns for 5 years | 21.18 | 169.74 | 12% |
| Returns for 10 years | 135.56 | 808.14 | 17% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| OEFA | 34.08 | 0.16 | +0.48% |
| ALPS O'Shares Intl Dev Qual Div ETF | |||
| BOXA | 105.36 | 0.12 | +0.11% |
| Alpha Architect Aggregate Bond ETF | |||
| XBOC | 35.40 | N/A | -0.01% |
| Innovator US Eq Acclrtd 9 Bffr ETF™ Oct | |||
| IYT | 83.98 | -0.85 | -1.00% |
| iShares Transportation Average ETF | |||
| BBH | 181.73 | -4.21 | -2.26% |
| VanEck Biotech ETF | |||